Playback speed
×
Share post
Share post at current time
0:00
/
0:00

Is 1 in 1,000 17-Year-Olds Taking Cross-Sex Hormones a Little Or A Lot?

My recent appearance on the Dollcast podcast about the buzzy new study out of Harvard examining the rates of gender-transition treatment among privately insured minors.

Hey all, in case you prefer digesting science news via video or just audio, here’s a relatively short video interview I gave to the Dollcast podcast about the new study I reported about last week about the rate of prescriptions of gender-transition drugs to privately insured minors. The two Substacks I’ve written about this study are below.

Hazard Ratio: Benjamin Ryan is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.


I am an independent journalist, specializing in science and health care coverage. I contribute to The New York Times, The Guardian, NBC News and The New York Sun. I have also written for theWashington Post, The Atlantic and The Nation. Follow me on Twitter: @benryanwriter and Bluesky: @benryanwriter.bsky.social. Visit my website: benryan.net

Hazard Ratio: Benjamin Ryan
Hazard Ratio: Benjamin Ryan Podcast
Independent health and science journalist Benjamin Ryan's Substack tends to focus on pediatric gender medicine in particular.